» Articles » PMID: 30842849

Label-free Plasmonic Nanostar Probes to Illuminate Membrane Receptor Recognition

Overview
Journal Chem Sci
Specialty Chemistry
Date 2019 Mar 8
PMID 30842849
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Protein-ligand recognition is a key activity where chemical signals are communicated to cells to activate various biochemical pathways, which are important for understanding membrane signaling and drug interactions. Gold nanostars are highly attractive for biological applications due to their readily modified surface chemistry, facile synthesis and optical properties. The increase in electromagnetic field at their branches increases the surface enhanced Raman scattering (SERS) making them ideal candidates as label free probes that can be used to detect a variety of cellular activities. However, the use of particles is complicated by the adsorption of proteins, which forms the protein corona. In this paper we demonstrate gold nanostars as label free probes to study the interaction between αβ integrin and RGD. Nanostars functionalized with cyclic-RDGFC reduced the formation of the protein corona, due to its zwitterionic nature, indicating a small peptide approach to minimizing protein absorption. Additionally, the functionalized nanostars evince a SERS response from their interaction with αβ integrin representative of the amino acids present at the binding site which is also retained in a complex biological matrix. The nanostars were used to selectively detect αβ integrin on the membrane of human metastatic colon cancer cells. By exploiting the intense SERS and tunable plasmon resonance properties of gold nanostars functionalized with cyclic RGDFC, we have demonstrated a label free approach to investigate the chemical interactions associated with protein-ligand binding from both purified proteins and membrane bound receptors in cells.

Citing Articles

Cancer Cell Targeting, Magnetic Sorting, and SERS Detection through Cell Surface Receptors.

Rist D, DePalma T, Stagner E, Tallman M, Venere M, Skardal A ACS Sens. 2023; 8(12):4636-4645.

PMID: 37988612 PMC: 10921760. DOI: 10.1021/acssensors.3c01625.


Design and Synthesis of SERS Materials for In Vivo Molecular Imaging and Biosensing.

Li Q, Huo H, Wu Y, Chen L, Su L, Zhang X Adv Sci (Weinh). 2023; 10(8):e2202051.

PMID: 36683237 PMC: 10015885. DOI: 10.1002/advs.202202051.


Surface enhanced Raman scattering for probing cellular biochemistry.

Spedalieri C, Kneipp J Nanoscale. 2022; 14(14):5314-5328.

PMID: 35315478 PMC: 8988265. DOI: 10.1039/d2nr00449f.


Probing protein aggregation at buried interfaces: distinguishing between adsorbed protein monomers, dimers, and a monomer-dimer mixture .

Lu T, Guo W, Datar P, Xin Y, Marsh E, Chen Z Chem Sci. 2022; 13(4):975-984.

PMID: 35211262 PMC: 8790787. DOI: 10.1039/d1sc04300e.


From Raman to SESORRS: moving deeper into cancer detection and treatment monitoring.

Sloan-Dennison S, Laing S, Graham D, Faulds K Chem Commun (Camb). 2021; 57(93):12436-12451.

PMID: 34734952 PMC: 8609625. DOI: 10.1039/d1cc04805h.


References
1.
Moyano D, Saha K, Prakash G, Yan B, Kong H, Yazdani M . Fabrication of corona-free nanoparticles with tunable hydrophobicity. ACS Nano. 2014; 8(7):6748-55. PMC: 4215884. DOI: 10.1021/nn5006478. View

2.
Danhier F, Le Breton A, Preat V . RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm. 2012; 9(11):2961-73. DOI: 10.1021/mp3002733. View

3.
Docter D, Westmeier D, Markiewicz M, Stolte S, Knauer S, Stauber R . The nanoparticle biomolecule corona: lessons learned - challenge accepted?. Chem Soc Rev. 2015; 44(17):6094-121. DOI: 10.1039/c5cs00217f. View

4.
Kim J, Kim J, Choi H, Lee S, Jun B, Yu K . Nanoparticle probes with surface enhanced Raman spectroscopic tags for cellular cancer targeting. Anal Chem. 2006; 78(19):6967-73. DOI: 10.1021/ac0607663. View

5.
Huang T, Huang S, Li M, Zeng Z, Wang X, Ren B . Tip-enhanced Raman spectroscopy: tip-related issues. Anal Bioanal Chem. 2015; 407(27):8177-95. DOI: 10.1007/s00216-015-8968-8. View